CISXF yields 1.54% · PFE yields 6.13%● Live data
📍 CISXF pulled ahead of the other in Year 1
Combined, CISXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CISXF + PFE for your $10,000?
China Steel Corporation manufactures and sells steel products in Taiwan, Vietnam, Malaysia, China, India, and internationally. It offers steel plates primarily for use in construction structures, shipbuilding, bridge beams, oil country tabular goods, machine structures, pressure vessels, and in climate/corrosion-resistant steel plates; steel bars and wire rods for use in general and machine structures, cold forging, hot forging, hard drawn steel wires, and welding electrodes; and hot-rolled coils and sheets that are used in automobile chassis, bridge beams, construction, road guardrails, steel pipe, pressure vessels, and landscaping. The company also provides cold-rolled coils for use in automobile stamping parts and home electronics products; parts requiring high-level forming, such as automobile and scooter components; a variety of PSE and structural reinforcement parts; and products requiring surface coating treatment, such as painting, electroplating, and the application of adhesive surfaces. In addition, it offers mechanical, communications, and electrical engineering services; and generates solar power. The company was incorporated in 1971 and is headquartered in Kaohsiung, Taiwan.
Full CISXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.